369 related articles for article (PubMed ID: 11332289)
21. HLA and leprosy in the pre and postgenomic eras.
Geluk A; Ottenhoff TH
Hum Immunol; 2006 Jun; 67(6):439-45. PubMed ID: 16728267
[TBL] [Abstract][Full Text] [Related]
22. Comparison of PCR mediated amplification of DNA and the classical methods for detection of Mycobacterium leprae in different types of clinical samples in leprosy patients and contacts.
Torres P; Camarena JJ; Gomez JR; Nogueira JM; Gimeno V; Navarro JC; Olmos A
Lepr Rev; 2003 Mar; 74(1):18-30. PubMed ID: 12669929
[TBL] [Abstract][Full Text] [Related]
23. Quantitation of IgM antibodies to the M. leprae synthetic disaccharide can predict early bacterial multiplication in leprosy.
Hussain R; Jamil S; Kifayet A; Firdausi F; Dockrell HM; Lucas S; Hasan R
Int J Lepr Other Mycobact Dis; 1990 Sep; 58(3):491-502. PubMed ID: 2205684
[TBL] [Abstract][Full Text] [Related]
24. Changes in the size and number of skin lesions in PB leprosy on treatment and follow-up.
Rao PN; Suneetha S; Pratap DV
Lepr Rev; 2011 Sep; 82(3):244-52. PubMed ID: 22125932
[TBL] [Abstract][Full Text] [Related]
25. Field utility of phenolic glycolipid coated latex agglutination test for rapid detection of bacilliferous leprosy cases.
Vaishnavi C; Agnihotri N; Kumar B; Kaur S; Ganguly NK
J Hyg Epidemiol Microbiol Immunol; 1992; 36(2):169-73. PubMed ID: 1512452
[TBL] [Abstract][Full Text] [Related]
26. Association between anti-pGL-I IgM and clinical and demographic parameters in leprosy.
Schuring RP; Moet FJ; Pahan D; Richardus JH; Oskam L
Lepr Rev; 2006 Dec; 77(4):343-55. PubMed ID: 17343221
[TBL] [Abstract][Full Text] [Related]
27. ML0405 and ML2331 are antigens of Mycobacterium leprae with potential for diagnosis of leprosy.
Reece ST; Ireton G; Mohamath R; Guderian J; Goto W; Gelber R; Groathouse N; Spencer J; Brennan P; Reed SG
Clin Vaccine Immunol; 2006 Mar; 13(3):333-40. PubMed ID: 16522774
[TBL] [Abstract][Full Text] [Related]
28. Assessment of anti-PGL-I as a prognostic marker of leprosy reaction.
Stefani MM; Martelli CM; Morais-Neto OL; Martelli P; Costa MB; de Andrade AL
Int J Lepr Other Mycobact Dis; 1998 Sep; 66(3):356-64. PubMed ID: 9934362
[TBL] [Abstract][Full Text] [Related]
29. Antibody response to phenolic glycolipid I and Mycobacterium w antigens and its relation to bacterial load in M. leprae-infected mice and leprosy patients.
Moudgil KD; Gupta SK; Naraynan PR; Srivastava LM; Mishra RS; Talwar GP
Clin Exp Immunol; 1989 Nov; 78(2):214-8. PubMed ID: 12412751
[TBL] [Abstract][Full Text] [Related]
30. Utility of measuring serum levels of anti-PGL-I antibody, neopterin and C-reactive protein in monitoring leprosy patients during multi-drug treatment and reactions.
Silva EA; Iyer A; Ura S; Lauris JR; Naafs B; Das PK; Vilani-Moreno F
Trop Med Int Health; 2007 Dec; 12(12):1450-8. PubMed ID: 18076551
[TBL] [Abstract][Full Text] [Related]
31. Diagnosing leprosy: revisiting the role of the slit-skin smear with critical analysis of the applicability of polymerase chain reaction in diagnosis.
Banerjee S; Biswas N; Kanti Das N; Sil A; Ghosh P; Hasanoor Raja AH; Dasgupta S; Kanti Datta P; Bhattacharya B
Int J Dermatol; 2011 Dec; 50(12):1522-7. PubMed ID: 22097999
[TBL] [Abstract][Full Text] [Related]
32. IgM antibodies against phenolic glycolipid I from Mycobacterium leprae in leprosy sera: relationship to bacterial index and erythema nodosum leprosum.
Schwerer B; Meeker HC; Sersen G; Levis WR
Acta Leprol; 1984; 2(2-4):394-402. PubMed ID: 6398598
[TBL] [Abstract][Full Text] [Related]
33. Revalidation of various clinical criteria for the classification of leprosy--a clinic-pathological study.
Gupta R; Kar HK; Bharadwaj M
Lepr Rev; 2012 Dec; 83(4):354-62. PubMed ID: 23614253
[TBL] [Abstract][Full Text] [Related]
34. Long-term culture of multibacillary leprosy macrophages isolated from skin lesions: a new model to study Mycobacterium leprae-human cell interaction.
Moura DF; Teles RM; Ribeiro-Carvalho MM; Teles RB; Santos IM; Ferreira H; Fulco TO; Nery JA; Sampaio EP; Sarno EN
Br J Dermatol; 2007 Aug; 157(2):273-83. PubMed ID: 17553031
[TBL] [Abstract][Full Text] [Related]
35. Use of protein antigens for early serological diagnosis of leprosy.
Duthie MS; Goto W; Ireton GC; Reece ST; Cardoso LP; Martelli CM; Stefani MM; Nakatani M; de Jesus RC; Netto EM; Balagon MV; Tan E; Gelber RH; Maeda Y; Makino M; Hoft D; Reed SG
Clin Vaccine Immunol; 2007 Nov; 14(11):1400-8. PubMed ID: 17898185
[TBL] [Abstract][Full Text] [Related]
36. Mycobacterium leprae particle agglutination in diagnosis and monitoring of treatment of leprosy.
Kampirapap K
J Med Assoc Thai; 1999 Oct; 82(10):1020-4. PubMed ID: 10561966
[TBL] [Abstract][Full Text] [Related]
37. Rapid method for diagnosis of leprosy by measurements of antibodies to the M. leprae 35-kDa protein: comparison with PGL-I antibodies detected by ELISA and "dipstick" methods.
Roche PW; Failbus SS; Britton WJ; Cole R
Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):279-86. PubMed ID: 10575407
[TBL] [Abstract][Full Text] [Related]
38. PGL-I antigen and antibody detection in leprosy patients: evolution under chemotherapy.
Chanteau S; Cartel JL; Celerier P; Plichart R; Desforges S; Roux J
Int J Lepr Other Mycobact Dis; 1989 Dec; 57(4):735-43. PubMed ID: 2681456
[TBL] [Abstract][Full Text] [Related]
39. A comparative and combinatorial study on two serological assays for detection of Mycobacterium leprae infection.
Parkash O; Girdhar BK
Acta Leprol; 2001-2002; 12(2):63-9. PubMed ID: 12136738
[TBL] [Abstract][Full Text] [Related]
40. Defective monocyte chemotaxis in active lepromatous leprosy.
Schuller-Levis G; Harris D; Cutler E; Meeker HC; Haubenstock H; Levis WR
Int J Lepr Other Mycobact Dis; 1987 Jun; 55(2):267-72. PubMed ID: 3298473
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]